Genmab A/S Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Genmab A/S (GNMSF) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of -$3.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2026-02-17
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | -$3.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $92.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | -$66.00M 20-F · filed 2026-02-17 |